Form D Explorer

Inspect source fieldsReport a record issue

Form D — Merge Bio Therapeutics Corp

0001231919-25-000205 · filed Sep 17, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Other filings

Offering

Industry
Other
Exemptions
Rule 506(b)
Reported offering amount
$14,999,979
Reported amount sold
$4,999,998
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Merge Bio Therapeutics Corp
CIK
2086124
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2025
Address
1 KENDALL SQUARE, BUILDING 200
CAMBRIDGE, Massachusetts 02139
Phone
617-286-2631

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗